tirzepatide compound dosage Chart & Dosing Guide for Weight Loss Compounded Tirzepatide for Weight Loss

PMID 24653790

The condition extends the telogen (resting) phase whilst simultaneously reducing the anagen (growth) phase duration

The 7.2 mg dose provides additional weight loss for those who need it

21% Average weight loss at 12 months: Members combining GLP-1 medications with support from WW Med+ 1 29.1% More weight loss: Members who engaged regularly with the GLP-1 Success Program at 12 months 2 87% Blood pressure change: Members prescribed weight loss medications through WW Med+ who had high blood pressure when starting, had normal blood pressure after 12 months 3 0.75 Decrease in HbA1c at six months: Members participating in the Weight Watchers Diabetes Program 4 Our consultative approach fits your priorities Our focus is on helping you define the right weight management strategy to solve your biggest weight health challenges